Fachklinik Bad Bentheim

Bad Bentheim, North Rhine-Westphalia 48455

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Psoriasis

Studies at this site

• Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis — Completed
• A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2) — Completed